Zheng Quan Shi Bao Wang·2025-09-01 09:57Core Viewpoint - Baiyunshan (600332) announced that its subsidiary Tianxin Pharmaceutical has received approval from the National Medical Products Administration for the supplementary application of two injectable drugs, indicating a successful evaluation of their quality and efficacy consistency as generic drugs [1] Group 1: Product Approval - Tianxin Pharmaceutical's injectable drugs, including Cefoperazone Sodium and Sulbactam Sodium (1.0g, 1.5g, 2.0g) and Clindamycin Phosphate Injection (2ml: 0.3g, 4ml: 0.6g), have passed the consistency evaluation for generic drug quality and efficacy [1] - Cefoperazone Sodium and Sulbactam Sodium is a third-generation cephalosporin antibiotic, suitable for treating respiratory infections caused by sensitive bacteria [1] - Clindamycin Phosphate Injection is primarily used for severe infections caused by sensitive anaerobic bacteria [1]